Public and investor relations for the innovators in healthcare and technology

We’ve been delivering measurable PR and IR results for innovative companies in health and technology since our founding more than 30 years ago originally as Noonan/Russo Communications.  When it comes to raising awareness of your company and product as well as forging new relationships, no one connects you to the people you want to know like we do. Our team of PhD-level scientists, former journalists, TV producers, and Wall Street professionals is on a first-name basis with the who’s who in media, finance, medicine and technology.

Pharmacy head who researched Zantac link to carcinogen says FDA has ‘downplayed the problem’

Last week, regulators in the U.S. and Europe disclosed that the same carcinogen that led to numerous recalls over the past year of valsartan and similar blood pressure pills was found in Zantac and other antacid medicines known as ranitidines. The Food and Drug Administration, however, was first alerted to the presence of the carcinogen, […]

read more
Bloomington startup’s device is making it easier to walk in a cast
| Star Tribune

A Bloomington startup called SubioMed wants to put a new spring in your step. Based on technology invented by a Minnesota podiatrist, SubioMed is developing a line of hinged carbon-fiber devices worn on the bottom of a cast or inside a “boot” brace that use a springlike mechanism to make it easier to walk more […]

read more
Zantac Has Low Levels of a Cancer-Causing Chemical, the F.D.A. Says
| The New York Times

The Food and Drug Administration said on Friday that it had detected low levels of a cancer-causing contaminant in samples of heartburn medicines containing the drug commonly known as Zantac. It was advising patients who take over-the-counter versions to consider switching to a different medication. But no recalls have been initiated, and the agency said patients who take […]

read more